Leuprolide Acetate: Advanced prostate cancer treatment
Health

Leuprolide Acetate: Advanced prostate cancer treatment

Mary kudro
Mary kudro
1 min read

Healthcare professionals use the drug Leuprolide Acetate in the palliative treatment of patients with advanced prostate cancer. Leuprolide acetate is available as a sterile, aqueous solution intended for subcutaneous injection. Leuprolide Acetate is an LH-RH agonist that acts as a potent inhibitor of gonadotropin secretion when given continuously and in therapeutic doses. Animal and human studies indicate that following an initial stimulation of gonadotropins, chronic administration of leuprolide acetate results in ovarian and testicular steroidogenesis suppression. The drug is supplied in 3.75 mg, 11.25 mg, and 22.5 mg single-dose vials to administer subcutaneously. The active ingredient in the vials is Leuprolide acetate with inactive ingredients purified gelatin, DL-lactic and glycolic acid copolymer, and D-mannitol. The side effects of Leuprolide acetate are malaise, fatigue, hot flashes/sweats, and testicular atrophy. 

Leuprolide acetate cost is reasonable, and one can purchase this medicine from any nearby licensed pharmaceutical suppliers. For more information about this medicine, please ring us on 18008891064.

0

Discussion (0 comments)

0 comments

No comments yet. Be the first!